Bradley Brown

Bradley Brown is a life sciences executive with broad experience across the biotechnology, pharmaceutical, and medical device sectors. Brad has 20+ years of experience in corporate operations and clinical research, with an emphasis on strategic development and the execution of multinational clinical programs. Brad has contributed significantly to the development and execution of numerous clinical studies for the advancement of emerging new medical devices and novel technologies that have addressed unmet clinical needs within interventional cardiology, peripheral vascular, structural heart, and cardiovascular diagnostics. Prior to joining ICS, Brad co-founded G3 Therapeutics and has held leadership positions for Keystone Heart, Novate Medical, CardioDx, Ostial Corporation, and Abbott Vascular. He has co-authored several scientific publications in advanced cardiovascular imaging, genetics, and metabolomics. Brad holds a BS in Exercise Science from the University of New England, an MS in Cardiac Rehabilitation & Exercise Science from East Stroudsburg University, and an MBA from Virginia Commonwealth University.